top of page
ESGCT_Academy26_Banner_1920x400px.jpg

ACADEMY PROGRAMME

Check the programme regularly for updates

Wednesday 14 January

11:30-12:00

Welcome 

Introduction round and selection of the order of the student presentation

12:00-12:45           

Lunch

12:45-13:30           
Hildegard Büning, Hannover Medical School

Adeno-Associated Virus (AAV) vectors as delivery tools in neuromuscular diseases

 

​​​​​13:30-14:00           

Capucine Trollet, Institut de Myologie

Cell and Gene Therapy Approaches for Oculopharyngeal Muscular Dystrophy

​

14:00-15:30  Student talks 1, 2

15:30-16:00

Coffee Break​

16:00-16:30           

Mario Amendola, Genethon

Genome Editing and AAV Delivery for Utrophin-mediated Duchenne Muscular Dystrophy Therapy

​

16:30-18:00  Student talks 4

18:30

Surprise Networking evening

Wed

Thursday 15 January

09:00-09:30

Isabelle Richard, Genethon

Therapeutic Challenges in Muscular Dystrophies


09:30-10:00

Federic Relaix, UPEC Health Faculty, INSERM, ENVA, EFS & APHP

Rat Duchenne muscular dystrophy models for preclinical studies and deciphering tissue repair mechanisms

​

10:00-11:00  Student talks 5 & 6

11:00-11:30
Coffee Break 

11:30-12:00
Sonia Albini, Genethon

Profibrotic iPSC-derived MYOrganoids as a translational model for gene therapy evaluation in Duchenne Muscular Dystrophy


12:00-13:00  Student talks 7 & 8​

13:00-14:00
Lunch

14:00-14:30

Sumitava Dastidar, UCL

Human Multi-Organoid Platform for Preclinical Evaluation of Neuromuscular Gene Therapies

​

14:30-15:30  Student talks 9, 10​​

15:30-16:00
Coffee Break 

16:00-17:00

Gloria González-Aseguinolaza, CIMA, University of Navarra, Pamplona

Between academia and industry: juggling roles to deliver solutions to patients

​

17:00-18:30

Visit TARGET Lab

19:30-

Dinner

Thu

Friday 16 January

09:15-10:00

Yann Pereon, Rare Diseases Reference Center at Nantes University Hospital

Gene therapy treatments for patients with neuromuscular diseases​
 

10:00-10:45

Discussion with parent of 2 young patients       

10:45-11:15         

Coffee Break 

11:15-12:00  

Caroline Le Guiner, Target, Nantes

Gene therapy for Duchenne Muscular Dystrophy: The journey of an rAAV-µDystrophin product

​

12:00-12:15          

Closing

Friday
bottom of page